119th Congress

S. 2513

OTC Monograph Drug User Fee Transparency Act

Introduced
In committee
Passed Senate
Passed House
To President
Became law

Sponsor: Tim Kaine(D-VA)
Introduced: Jul 29, 2025
Policy area: Health
Committees: Senate Committee on Health, Education, Labor, and Pensions
Official text: Introduced in Senate · Congress.gov page

Cosponsors (0)

No cosponsors.

Summary

No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.

Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to transparency and reporting regarding over-the-counter drug monograph activities, and for other purposes.

Latest action(Jul 29, 2025): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Read the official text

Roll-call votes

No recorded votes on this bill.

Actions

Jul 29, 2025 · Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jul 29, 2025
Introduced in Senate